HEADER BIOSYNTHETIC PROTEIN 17-JUN-21 7OWB TITLE CHIMERIC CARMINOMYCIN-4-O-METHYLTRANSFERASE (DNRK) WITH A REGION FROM TITLE 2 10-HYDROXYLASE CALMB COMPND MOL_ID: 1; COMPND 2 MOLECULE: CARMINOMYCIN 4-O-METHYLTRANSFERASE DNRK,METHYLTRANSFERASE COMPND 3 DOMAIN-CONTAINING PROTEIN; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: COMT,ANTHRACYCLINE 4-O-METHYLTRANSFERASE; COMPND 6 EC: 2.1.1.292; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES PEUCETIUS, STREPTOMYCES SP. SOURCE 3 ZEA17I; SOURCE 4 ORGANISM_TAXID: 1950, 2202516; SOURCE 5 GENE: DNRK, DKT74_09280; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: TOP10 KEYWDS CARMINOMYCIN-4-O-METHYLTRANSFERASE VARIANT; CHIMERAGENESIS; KEYWDS 2 ACLACINOMYCIN 10-HYDROXYLASE, BIOSYNTHETIC PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR P.DINIS,M.METSAKETELA REVDAT 3 07-FEB-24 7OWB 1 REMARK REVDAT 2 22-MAR-23 7OWB 1 JRNL REVDAT 1 13-JUL-22 7OWB 0 JRNL AUTH P.DINIS,H.TIRKKONEN,B.N.WANDI,V.SIITONEN,J.NIEMI, JRNL AUTH 2 T.GROCHOLSKI,M.METSA-KETELA JRNL TITL EVOLUTION-INSPIRED ENGINEERING OF ANTHRACYCLINE JRNL TITL 2 METHYLTRANSFERASES. JRNL REF PNAS NEXUS V. 2 AD009 2023 JRNL REFN ESSN 2752-6542 JRNL PMID 36874276 JRNL DOI 10.1093/PNASNEXUS/PGAD009 REMARK 2 REMARK 2 RESOLUTION. 2.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.87 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 15808 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.248 REMARK 3 R VALUE (WORKING SET) : 0.247 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.880 REMARK 3 FREE R VALUE TEST SET COUNT : 771 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.8700 - 4.4500 0.99 2653 129 0.1867 0.2175 REMARK 3 2 4.4500 - 3.5300 0.99 2532 127 0.2123 0.1954 REMARK 3 3 3.5300 - 3.0900 1.00 2518 122 0.2578 0.2743 REMARK 3 4 3.0900 - 2.8000 1.00 2470 132 0.3319 0.3660 REMARK 3 5 2.8000 - 2.6000 1.00 2494 126 0.3769 0.4269 REMARK 3 6 2.6000 - 2.4500 0.97 2370 135 0.4521 0.4396 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.445 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.150 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 51.87 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.76 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.011 2616 REMARK 3 ANGLE : 1.414 3580 REMARK 3 CHIRALITY : 0.079 429 REMARK 3 PLANARITY : 0.034 453 REMARK 3 DIHEDRAL : 17.166 929 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7OWB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-JUN-21. REMARK 100 THE DEPOSITION ID IS D_1292116437. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-MAY-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : MASSIF-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.987 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15812 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.450 REMARK 200 RESOLUTION RANGE LOW (A) : 44.870 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 5.690 REMARK 200 R MERGE (I) : 0.13500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.1900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.96800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.560 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 1TW2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M POTASSIUM THIOCYANATE, 0.1 M BIS REMARK 280 -TRIS PROPANE, 20 % W/V PEG 3350, PH 7.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 30.40000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 51.56850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.40000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 51.56850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5890 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26110 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -48.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 60.80000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -9 REMARK 465 ALA A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 ARG A 0 REMARK 465 SER A 1 REMARK 465 THR A 2 REMARK 465 ALA A 3 REMARK 465 GLU A 4 REMARK 465 PRO A 5 REMARK 465 THR A 6 REMARK 465 VAL A 7 REMARK 465 ALA A 8 REMARK 465 ALA A 9 REMARK 465 ARG A 10 REMARK 465 PRO A 11 REMARK 465 GLN A 12 REMARK 465 PRO A 288 REMARK 465 SER A 289 REMARK 465 PRO A 290 REMARK 465 ASP A 291 REMARK 465 GLU A 292 REMARK 465 THR A 293 REMARK 465 THR A 294 REMARK 465 SER A 295 REMARK 465 PRO A 340 REMARK 465 SER A 341 REMARK 465 PRO A 342 REMARK 465 ALA A 357 REMARK 465 THR A 358 REMARK 465 GLY A 359 REMARK 465 ALA A 360 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 13 CG CD OE1 NE2 REMARK 470 ASP A 15 CG OD1 OD2 REMARK 470 ARG A 49 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 85 CG CD OE1 OE2 REMARK 470 ASP A 163 CG OD1 OD2 REMARK 470 ASP A 165 CG OD1 OD2 REMARK 470 ARG A 181 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 229 CG OD1 OD2 REMARK 470 ARG A 285 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 319 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 334 CG CD OE1 OE2 REMARK 470 ARG A 337 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 338 CG CD OE1 NE2 REMARK 470 TYR A 346 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP A 347 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 174 -5.60 -59.80 REMARK 500 GLU A 284 -162.88 -160.98 REMARK 500 TYR A 346 134.48 -173.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1TW2 RELATED DB: PDB REMARK 900 1TW2 CONTAINS THE WILD-TYPE VERSION OF THE CHIMERIC CONSTRUCT DBREF 7OWB A 2 285 UNP Q06528 DNRK_STRPE 2 285 DBREF1 7OWB A 286 303 UNP A0A2V2Q0Q4_9ACTN DBREF2 7OWB A A0A2V2Q0Q4 257 274 DBREF 7OWB A 304 360 UNP Q06528 DNRK_STRPE 300 356 SEQADV 7OWB MET A -9 UNP Q06528 INITIATING METHIONINE SEQADV 7OWB ALA A -8 UNP Q06528 EXPRESSION TAG SEQADV 7OWB HIS A -7 UNP Q06528 EXPRESSION TAG SEQADV 7OWB HIS A -6 UNP Q06528 EXPRESSION TAG SEQADV 7OWB HIS A -5 UNP Q06528 EXPRESSION TAG SEQADV 7OWB HIS A -4 UNP Q06528 EXPRESSION TAG SEQADV 7OWB HIS A -3 UNP Q06528 EXPRESSION TAG SEQADV 7OWB HIS A -2 UNP Q06528 EXPRESSION TAG SEQADV 7OWB HIS A -1 UNP Q06528 EXPRESSION TAG SEQADV 7OWB ARG A 0 UNP Q06528 EXPRESSION TAG SEQADV 7OWB SER A 1 UNP Q06528 EXPRESSION TAG SEQRES 1 A 370 MET ALA HIS HIS HIS HIS HIS HIS HIS ARG SER THR ALA SEQRES 2 A 370 GLU PRO THR VAL ALA ALA ARG PRO GLN GLN ILE ASP ALA SEQRES 3 A 370 LEU ARG THR LEU ILE ARG LEU GLY SER LEU HIS THR PRO SEQRES 4 A 370 MET VAL VAL ARG THR ALA ALA THR LEU ARG LEU VAL ASP SEQRES 5 A 370 HIS ILE LEU ALA GLY ALA ARG THR VAL LYS ALA LEU ALA SEQRES 6 A 370 ALA ARG THR ASP THR ARG PRO GLU ALA LEU LEU ARG LEU SEQRES 7 A 370 ILE ARG HIS LEU VAL ALA ILE GLY LEU LEU GLU GLU ASP SEQRES 8 A 370 ALA PRO GLY GLU PHE VAL PRO THR GLU VAL GLY GLU LEU SEQRES 9 A 370 LEU ALA ASP ASP HIS PRO ALA ALA GLN ARG ALA TRP HIS SEQRES 10 A 370 ASP LEU THR GLN ALA VAL ALA ARG ALA ASP ILE SER PHE SEQRES 11 A 370 THR ARG LEU PRO ASP ALA ILE ARG THR GLY ARG PRO THR SEQRES 12 A 370 TYR GLU SER ILE TYR GLY LYS PRO PHE TYR GLU ASP LEU SEQRES 13 A 370 ALA GLY ARG PRO ASP LEU ARG ALA SER PHE ASP SER LEU SEQRES 14 A 370 LEU ALA CYS ASP GLN ASP VAL ALA PHE ASP ALA PRO ALA SEQRES 15 A 370 ALA ALA TYR ASP TRP THR ASN VAL ARG HIS VAL LEU ASP SEQRES 16 A 370 VAL GLY GLY GLY LYS GLY GLY PHE ALA ALA ALA ILE ALA SEQRES 17 A 370 ARG ARG ALA PRO HIS VAL SER ALA THR VAL LEU GLU MET SEQRES 18 A 370 ALA GLY THR VAL ASP THR ALA ARG SER TYR LEU LYS ASP SEQRES 19 A 370 GLU GLY LEU SER ASP ARG VAL ASP VAL VAL GLU GLY ASP SEQRES 20 A 370 PHE PHE GLU PRO LEU PRO ARG LYS ALA ASP ALA ILE ILE SEQRES 21 A 370 LEU SER PHE VAL LEU LEU ASN TRP PRO ASP HIS ASP ALA SEQRES 22 A 370 VAL ARG ILE LEU THR ARG CYS ALA GLU ALA LEU GLU PRO SEQRES 23 A 370 GLY GLY ARG ILE LEU ILE HIS GLU ARG ALA GLU PRO SER SEQRES 24 A 370 PRO ASP GLU THR THR SER THR ALA ASP LEU HIS PHE SER SEQRES 25 A 370 LEU LEU ASP LEU ARG MET LEU VAL PHE LEU GLY GLY ALA SEQRES 26 A 370 LEU ARG THR ARG GLU LYS TRP ASP GLY LEU ALA ALA SER SEQRES 27 A 370 ALA GLY LEU VAL VAL GLU GLU VAL ARG GLN LEU PRO SER SEQRES 28 A 370 PRO THR ILE PRO TYR ASP LEU SER LEU LEU VAL LEU ALA SEQRES 29 A 370 PRO ALA ALA THR GLY ALA HET 3VL A 401 41 HET SAH A 402 26 HETNAM 3VL METHYL (1R,2R,4S)-2-ETHYL-2,5,7-TRIHYDROXY-6,11-DIOXO- HETNAM 2 3VL 4-{[2,3,6-TRIDEOXY-3-(DIMETHYLAMINO)-ALPHA-L-LYXO- HETNAM 3 3VL HEXOPYRANOSYL]OXY}-1,2,3,4,6,11-HEXAHYDROTETRACENE-1- HETNAM 4 3VL CARBOXYLATE HETNAM SAH S-ADENOSYL-L-HOMOCYSTEINE HETSYN 3VL ACLACINOMYCIN T FORMUL 2 3VL C30 H35 N O10 FORMUL 3 SAH C14 H20 N6 O5 S FORMUL 4 HOH *32(H2 O) HELIX 1 AA1 GLN A 13 GLY A 24 1 12 HELIX 2 AA2 LEU A 26 LEU A 38 1 13 HELIX 3 AA3 ARG A 39 ALA A 46 1 8 HELIX 4 AA4 THR A 50 ASP A 59 1 10 HELIX 5 AA5 ARG A 61 ILE A 75 1 15 HELIX 6 AA6 VAL A 91 ALA A 96 5 6 HELIX 7 AA7 ARG A 104 ASP A 108 5 5 HELIX 8 AA8 GLN A 111 ASP A 117 1 7 HELIX 9 AA9 ILE A 118 THR A 121 5 4 HELIX 10 AB1 ARG A 122 GLY A 130 1 9 HELIX 11 AB2 THR A 133 GLY A 139 1 7 HELIX 12 AB3 PRO A 141 ARG A 149 1 9 HELIX 13 AB4 ARG A 149 ALA A 161 1 13 HELIX 14 AB5 PHE A 168 ALA A 174 1 7 HELIX 15 AB6 GLY A 191 ARG A 199 1 9 HELIX 16 AB7 GLY A 213 GLU A 225 1 13 HELIX 17 AB8 VAL A 254 TRP A 258 5 5 HELIX 18 AB9 PRO A 259 ALA A 273 1 15 HELIX 19 AC1 ALA A 297 PHE A 311 1 15 HELIX 20 AC2 THR A 318 ALA A 329 1 12 SHEET 1 AA1 2 LEU A 78 GLU A 80 0 SHEET 2 AA1 2 PHE A 86 PRO A 88 -1 O VAL A 87 N GLU A 79 SHEET 1 AA2 7 VAL A 231 GLU A 235 0 SHEET 2 AA2 7 SER A 205 GLU A 210 1 N VAL A 208 O VAL A 234 SHEET 3 AA2 7 HIS A 182 VAL A 186 1 N ASP A 185 O THR A 207 SHEET 4 AA2 7 ALA A 246 SER A 252 1 O ILE A 250 N LEU A 184 SHEET 5 AA2 7 LEU A 274 ARG A 285 1 O LEU A 281 N LEU A 251 SHEET 6 AA2 7 LEU A 348 PRO A 355 -1 O LEU A 353 N ILE A 280 SHEET 7 AA2 7 LEU A 331 LEU A 339 -1 N GLU A 334 O VAL A 352 CRYST1 60.800 103.137 66.485 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016447 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009696 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015041 0.00000